2021 IVD Market Update and COVID-19 Impact

What is the Size of the IVD Market in 2021? What Impact has COVID-19 Had on IVD Markets? What Major Trends are Affecting the Market in 2021?

Diagnostic test products have never been more important. This report, 2021 IVD Market Update and COVID-19 Impact, is an update of the market for in vitro diagnostics products from the report's analysts to reflect the latest information.

As part of its coverage, this report contains market sizing for the following categories of IVD:

• Clinical Chemistry
• Immunoassays - non isotopic
• Infectious disease
• Other immunos
• Blood bank screening
• Drugs of Abuse
• Diabetes HbA1c - lab
• Hematology - Core Lab
• Microbiology (ID/AST)
• Microbiology (molecular)
• Microbiology - Mass Spectrometry
• Radioimmunoassays
• Coagulation (PT/INR)
• Coagulation, molecular
• Histology/cytology
• HPV, molecular
• Nucleic acid assays
• Blood grouping/typing
• Blood bank molecular
• NAT Blood Screens
• Circulating tumor cells
• POC, OTC diabetes
• POC, OTC other
• POC, professional/hospital;
• COVID-19

Complete market figures and forecasts will be part of the Worldwide report in August.

How is COVID-19 Impacting the Market in 2021

This report does detail the effects of COVID-19 including the following:

• Effect of COVID-19 on Market Segments
• Table 1-3: IVD Market excluding and with COVID-19, 2020
• Figure 1-1: IVD Market Distribution by Segment
• Table 1-4: Global In Vitro Diagnostic Market - YoY Growth 2019-2020
• Figure 1-2: Global In Vitro Diagnostic Market - YoY Growth 2019-2020
• Figure 1-3: IVD Segment Performance, Q1 2020 - Q4 2020
• Figure 1-4: IVD Segment Performance, Total Market Value, 2020

Also included in this report:

• Product Trends and Developments
• COVID-19 Developments Sept. 2020 to Feb 2021
• Select IVD Market Participant Developments
• Competitive Leader Updates